New Drugs Approved in 2022

In 2022, the US Food and Drug Administration (FDA) approved 37 novel drugs. Twenty-four of the 37 (65%) novel drug approvals were reviewed and approved through an expedited review pathway and 20 of the 37 (54%) were approved for treatment of a rare disease. This review includes a summary of the novel drugs approved by the FDA in 2022.(c) 2023 Elsevier Inc. All rights reserved. center dot The American Journal of Medicine (2023) 136:545-550

Automated summary

In 2022, the FDA approved 37 novel drugs, with 24 (65%) of them being reviewed and approved through an expedited pathway and 20 (54%) approved for rare disease treatment. This article provides a summary of the novel drugs approved by the FDA in 2022.